Novel combination regimen for AMD shows favorable safety
April 1st 2010Preliminary results from a phase 1 safety and tolerability study show no dose-limiting toxicity so far in patients treated with intravitreal injections of volociximab in combination with anti-VEGF therapy for neovascular age-related macular degeneration.
2009 ISRS survey results highlight U.S. refractive surgery trends
April 1st 2010Results of the 2009 International Society of Refractive Surgery survey examining refractive surgery practice patterns in the United States show total surgical volume decreased while surgeons are continuing to embrace new techniques and technologies that can afford safer, more predictable outcomes.
Data show favorable outcomes for angle-supported phakic IOL
March 15th 2010Results from 3 years of follow-up in the phase II clinical trial investigating an angle-supported phakic IOL for the treatment of moderate to high myopia indicate this anterior chamber implant provides excellent visual acuity and is associated with accurate predictability of refraction and promising safety.
Medicare fee debate frustrates physicians
March 15th 2010As Congress continues to debate health-care reform and how best to pay physicians for providing medical care to the nation's neediest and elderly people, ophthalmologists are increasingly frustrated by the instability it wreaks upon their practices.